Topics

"Mitochondrial Dysfunction Atherosclerosis∨derfield=date∨derval=DESC" News Stories

17:57 EDT 24th August 2019 | BioPortfolio

Here are the most relevant search results for "Mitochondrial Dysfunction Atherosclerosis∨derfield=date∨derval=DESC" found in our extensive news archives from over 250 global news sources.

More Information about Mitochondrial Dysfunction Atherosclerosis∨derfield=date∨derval=DESC on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Mitochondrial Dysfunction Atherosclerosis∨derfield=date∨derval=DESC for you to read. Along with our medical data and news we also list Mitochondrial Dysfunction Atherosclerosis∨derfield=date∨derval=DESC Clinical Trials, which are updated daily. BioPortfolio also has a large database of Mitochondrial Dysfunction Atherosclerosis∨derfield=date∨derval=DESC Companies for you to search.

Showing "Mitochondrial Dysfunction Atherosclerosis derfield date derval DESC" News Articles 1–25 of 5,600+

Saturday 24th August 2019

Intuitive Surgical, Inc. Strategy, SWOT and Corporate Finance Report [Published by Marketline] Prices from USD $175

Intuitive Surgical, Inc. Strategy, SWOT and Corporate Finance ReportSummaryIntuitive Surgical, Inc. Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360 view of the company.Key HighlightsIntuitive Surgical, In...


Friday 23rd August 2019

An international team of researchers led by investigators at @ChildrensPhila has produced the largest genetic study to date associated with common childhood #obesity: http://ow.ly/xF3D50vH7gl 

An international team of researchers led by investigators at @ChildrensPhila has produced the largest genetic study to date associated with common childhood #obesity: http://ow.ly/xF3D50vH7gl 

Coronary Artery Disease CAD Ischemic Heart Disease Pipeline Review, H1 2019 [Published by Global Markets Direct] Prices from USD $2000

Coronary Artery Disease CAD Ischemic Heart Disease Pipeline Review, H1 2019SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Coronary Artery Disease CAD Ischemic Heart Disease Pipeline Review, H1 2019, provides an overview of the Coronary Artery Disease CAD Ischemic Heart Disease Cardiovascular pipeline landscape.Coronary artery disease CAD is the most co...


Injectable Drug Delivery Devices Medical Devices Pipeline Assessment, 2019 [Published by Global Data] Prices from USD $4000

Injectable Drug Delivery Devices Medical Devices Pipeline Assessment, 2019SummaryGlobalData's Medical Devices sector report, Injectable Drug Delivery Devices Medical Devices Pipeline Assessment, 2019" provides an overview of Injectable Drug Delivery Devices currently in pipeline stage.The report provides comprehensive information on the pipeline products with comparative analysis of the products...

Axcella Health Inc. Announces Appointment of Catherine A. Sohn, Pharm. D. to its Board of Directors

Axcella Health Inc. (Nasdaq: AXLA), a biotechnology company pioneering the research and development of novel multifactorial interventions using novel compositions of endogenous metabolic modulators to address dysregulated metabolism and support health, today announced that Catherine A. Sohn, Pharm.D. has been appointed to its Board of Directors. In addition, the Company announced that Christopher...

Human medicines European public assessment report (EPAR): Twynsta, telmisartan / amlodipine, Hypertension, Date of authorisation: 07/10/2010, Revision: 10, Status: Authorised

Human medicines European public assessment report (EPAR): Twynsta, telmisartan / amlodipine, Hypertension, Date of authorisation: 07/10/2010, Revision: 10, Status: Authorised

Human medicines European public assessment report (EPAR): Adynovi, rurioctocog alfa pegol, Hemophilia A, Date of authorisation: 08/01/2018, Revision: 3, Status: Authorised

Human medicines European public assessment report (EPAR): Adynovi, rurioctocog alfa pegol, Hemophilia A, Date of authorisation: 08/01/2018, Revision: 3, Status: Authorised

Agilent 8482H RF Power Sensor, 100 kHz to 4.2 GHz

C $658.45End Date: Monday Sep-23-2019 10:12:34 EDTBuy It Now for only: C $658.45Buy It Now | Add to watch list Biotech365 : Agilent 8482H RF Power Sensor, 100 kHz to 4.2 GHz BioMarketplace You want to propose your products or … Continue reading →

Geistlich Pharma AG Strategic SWOT Analysis Review [Published by Global Data] Prices from USD $125

Geistlich Pharma AG Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company's key employees, key competitors and major products and services.This uptotheminute company report will help you to formulate strategies to drive your business...

NEW In Box Agilent Standard Flowcell 10MM 13UL 120 BAR G1315-60012

$600.00End Date: Monday Sep-23-2019 1:32:29 PDTBuy It Now for only: $600.00Buy It Now | Add to watch list Biotech365 : NEW In Box Agilent Standard Flowcell 10MM 13UL 120 BAR G1315-60012 BioMarketplace You want to propose your products or a Biotech … Continue reading →

The Health Depot Association Awards Scholarships to Three Members’ Dependents

Funds to be applied to studies in biological science, nursing and design The Health Depot Association, a national, non-profit organization of entrepreneurs, self-employed professionals and contractors committed to providing access to benefits and resources to its members, has awarded college scholarships to three different recipients. Sonia Chinedu, a sophomore at the University of California,...

Human medicines European public assessment report (EPAR): NovoRapid, insulin aspart, Diabetes Mellitus, Date of authorisation: 07/09/1999, Revision: 30, Status: Authorised

Human medicines European public assessment report (EPAR): NovoRapid, insulin aspart, Diabetes Mellitus, Date of authorisation: 07/09/1999, Revision: 30, Status: Authorised

Ethnically Diverse GWAS Reveals New Child Obesity Locus

An international team of researchers who analyzed data across multiple ethnicities has produced the largest genetic study to date associated with common childhood obesity. The post Ethnically Diverse GWAS Reveals New Child Obesity Locus appeared first on GEN - Genetic Engineering and Biotechnology News.

Tenax Therapeutics Provides Clinical Development Update

Tenax Therapeutics, Inc. (Nasdaq: TENX), a specialty pharmaceutical company focused on identifying, developing and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical need, today provided an update on its on-going clinical trial of levosimendan. Clinical Development Update Tenax is conducting a multi-center, double-blind placebo controlled Phase...

Human medicines European public assessment report (EPAR): Venclyxto, venetoclax, Leukemia, Lymphocytic, Chronic, B-Cell, Date of authorisation: 04/12/2016, Revision: 8, Status: Authorised

Human medicines European public assessment report (EPAR): Venclyxto, venetoclax, Leukemia, Lymphocytic, Chronic, B-Cell, Date of authorisation: 04/12/2016, Revision: 8, Status: Authorised

Riveting Annual Regatta Raises Funds for Mobility-impaired Sailors

Shriners Hospitals for Children – Canada is proud to participate in the BNI Challenge that is taking place this Saturday, August 24, 2019, at the Royal Saint-Laurent Yacht Club in Dorval. Organized by members of the Royal St. Lawrence Yacht Club, in collaboration with other yacht clubs in the region, this fundraising event is benefitting the Association québécoise de voile adaptée (AQVA), an...

CStone announces data from trials of CS1001, CS1002 and CS1003 to be released for the first time at 2019 CSCO Annual Meeting

SUZHOU, China, Aug. 23, 2019 /PRNewswire/ -- CStone Pharmaceuticals ("CStone" or the "Company", HKEX: 2616) today announced that the 22nd Annual Meeting of the Chinese Society of Clinical Oncology (CSCO, 2019 CSCO Annual Meeting) has accepted three abstracts on the clinical trials of CS1001 (Anti-PD-L1 antibody), CS1002 (Anti-CTLA-4 antibody), and CS1003 (Anti-PD-1 antibody), t...

CStone completes registration filing for the Phase I trial of CDK4/6 inhibitor CS3002 in Australia and will soon initiate the study

SUZHOU, China, Aug. 23, 2019 /PRNewswire/ --  CStone Pharmaceuticals ("CStone" or the "Company", HKEX: 2616) today announced that the Company has recently received ethics approval from the Human Research Ethics Committee in Australia for the Phase I clinical trial of CS3002, and Australia's Therapeutic Goods Administration (TGA) has acknowledged the electronic Clinical Tri...

Human medicines European public assessment report (EPAR): Lojuxta, lomitapide, Hypercholesterolemia, Date of authorisation: 31/07/2013, Revision: 11, Status: Authorised

Human medicines European public assessment report (EPAR): Lojuxta, lomitapide, Hypercholesterolemia, Date of authorisation: 31/07/2013, Revision: 11, Status: Authorised

Practical Experiences and Challenges to Date with the Open-Source Value Project

That is the subtitle title of a paper by Jansen, Incerti and Linthicum (2019) in Pharmacoeconomics. The Innovation and Value Initiative started the Open-Source Value Project with the aim to improve the credibility and relevance of model-based value assessment in the context of the US healthcare environment. As a core activity of the Open-Source Value…

Thursday 22nd August 2019

An international team of scientists headed by @AllenInstitute researchers has generated what may be the most detailed “parts list” of the human brain to date: http://ow.ly/7ilI50vFYqz pic.twitter.com/tivbSwzGG7

An international team of scientists headed by @AllenInstitute researchers has generated what may be the most detailed “parts list” of the human brain to date: http://ow.ly/7ilI50vFYqz  pic.twitter.com/tivbSwzGG7

Digital Display Electric Thermostatic constant Temperature Water Bath 2019

$75.99 (0 Bids)End Date: Monday Aug-26-2019 20:01:30 PDTBid now | Add to watch list Biotech365 : Digital Display Electric Thermostatic constant Temperature Water Bath 2019 BioMarketplace You want to propose your products or a Biotech Company, a Biotech Tool or … Continue reading →

New Moticam Motic Microscope Digital Camera System Philip Harris Digiflex 130

£49.99End Date: Sunday Sep-8-2019 14:46:27 BSTBuy It Now for only: £49.99Buy It Now | Add to watch list Biotech365 : New Moticam Motic Microscope Digital Camera System Philip Harris Digiflex 130 BioMarketplace You want to propose your products or a … Continue reading →

Aptar Announces Capital Markets Day and Confirms Third Quarter Conference Call Date

CRYSTAL LAKE, Ill.–(BUSINESS WIRE)–AptarGroup, Inc. (NYSE: ATR), a global leader in dispensing, drug delivery and active packaging solutions, announced today that the company will host its Capital Markets Day in New York City, on Thursday, September 5, 2019. The event … Continue reading →

Vivus Inc VVUS Financial and Strategic SWOT Analysis Review [Published by Global Data] Prices from USD $125

Vivus Inc VVUS Financial and Strategic SWOT Analysis Review provides you an indepth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your busine...


Quick Search

News Quicklinks